v3.26.1
Award Timing Disclosure
 12 Months Ended
Dec. 31, 2025
Jan. 06, 2025
$ / shares
Jan. 02, 2025
USD ($)
shares
$ / shares
Award Timing Disclosures [Line Items]      
Award Timing MNPI Disclosure
We do not have any program, plan or obligation that requires us to grant equity awards on specified dates. We also do not have any program, plan or practice to time award dates of stock option grants to our executive officers in coordination with the release of material nonpublic information and typically our annual grants occur during an open trading window in the first quarter of the year. Equity awards may occasionally be granted following a significant change in job responsibilities or to meet special retention or performance objectives. In 2025, the Compensation Committee did not take material nonpublic information into account when determining the timing and terms of equity-based awards, including stock options, and the Company did not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation. During 2025, the Compensation Committee did grant annual stock option awards to our NEOs within the period beginning four business days before our filing of a periodic report on Form 10-K or Form 10-Q or the filing or furnishing of a current report on Form 8-K and ending one business day after the filing or furnishing of such report. Specifically, on January 6, 2025, the Company filed a Form 8-K disclosing that Dr. Suneel Gupta transitioned from his role as Chief Development Officer to Executive Vice President, Clinical Development. While the Company does not believe that the information disclosed on such Form 8-K was material nonpublic information, the Company is nevertheless providing the following information in accordance with SEC rules:
Name
​ ​
Grant Date
​ ​
Number of
Securities
Underlying
Award
​ ​
Exercise
Price(1)
​ ​
Grant Date
Fair Value
​ ​
Percentage Change in the Closing Market
Price of the Securities Underlying the Award
Between the Trading Day Ending Immediately
Prior to the Disclosure of Material Nonpublic
Information and the Trading Day Beginning
Immediately Following the Disclosure of
Material Nonpublic Information(2)
​
Dinesh V. Patel
​ ​ ​ ​ 1/2/2025 ​ ​ ​ ​ ​ 181,472 ​ ​ ​ ​ $ 38.98 ​ ​ ​ ​ $ 5,618,010 ​ ​ ​ ​ ​ (2.8)% ​ ​
Asif Ali
​ ​ ​ ​ 1/2/2025 ​ ​ ​ ​ ​ 38,520 ​ ​ ​ ​ $ 38.98 ​ ​ ​ ​ $ 1,192,502 ​ ​ ​ ​ ​ (2.8)% ​ ​
Arturo Molina
​ ​ ​ ​ 1/2/2025 ​ ​ ​ ​ ​ 49,862 ​ ​ ​ ​ $ 38.98 ​ ​ ​ ​ $ 1,543,628 ​ ​ ​ ​ ​ (2.8)% ​ ​
(1)
The exercise price of the reported stock option grants was higher than the closing price of the Company’s common stock on January 6, 2025 ($38.09).
(2)
This compares to a percentage change in the SPDR S&P Biotech ETF (NYSEARCA: XBI) over the same period of 0.5%.
   
Award Timing Method We do not have any program, plan or obligation that requires us to grant equity awards on specified dates. We also do not have any program, plan or practice to time award dates of stock option grants to our executive officers in coordination with the release of material nonpublic information and typically our annual grants occur during an open trading window in the first quarter of the year. Equity awards may occasionally be granted following a significant change in job responsibilities or to meet special retention or performance objectives.    
Award Timing Predetermined true    
Award Timing MNPI Considered false    
Award Timing, How MNPI Considered In 2025, the Compensation Committee did not take material nonpublic information into account when determining the timing and terms of equity-based awards, including stock options, and the Company did not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.    
MNPI Disclosure Timed for Compensation Value false    
Awards Close in Time to MNPI Disclosures      
Exercise Price   $ 38.09  
Underlying Security Market Price Change     0.5
Dinesh V. Patel [Member[      
Awards Close in Time to MNPI Disclosures      
Name     Dinesh V. Patel
Underlying Securities | shares     181,472
Exercise Price     $ 38.98
Fair Value as of Grant Date | $     $ 5,618,010
Underlying Security Market Price Change     (2.8)
Asif Ali [Member]      
Awards Close in Time to MNPI Disclosures      
Name     Asif Ali
Underlying Securities | shares     38,520
Exercise Price     $ 38.98
Fair Value as of Grant Date | $     $ 1,192,502
Underlying Security Market Price Change     (2.8)
Arturo Molina [Member]      
Awards Close in Time to MNPI Disclosures      
Name     Arturo Molina
Underlying Securities | shares     49,862
Exercise Price     $ 38.98
Fair Value as of Grant Date | $     $ 1,543,628
Underlying Security Market Price Change     (2.8)